Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases

IMPRiND

Assemblies of tau and α-synuclein were shown to spread along interconnected neuronal networks suggesting broadly relevant therapeutic directions for Alzheimer’s and Parkinson’s disease. This requires a pre-clinical stage of development that has yet to be met. The scale of neurodegenerative disease burden in Europe calls for an unprecedented...

Funding Programme
Start Date
End Date
Total Funding
€ 11 363 398
European Countries Involved

Initial Training Network for Neurogical disorders orchestrated by cytoKines

NEUROKINE

Neuroinflammatory disease, in particular multiple sclerosis affects more than 700.000 people within Europe alone. European countries are at the forefront of neuroimmunological research and students in medicine and biology are greatly attracted by the field. Neuroimmunology research further impacts our understanding of the ethiopathology of other...

Funding Programme
Start Date
End Date
Total Funding
€ 3 536 796

Innovative Midlife Intervention for Dementia deterrence

IN-MINDD

The European costs of dementia were estimated €177 billion and there is a growing gap between burden and budget. The debilitation associated with dementia makes it the most feared of conditions related to ageing . Modelling studies have estimated that if obesity rates dropped by 5%, dementia prevalence rates would be lower by 6% and a decline in...

Funding Programme
Start Date
End Date
Total Funding
€ 3 825 936
European Countries Involved

Insulin resistance and Tauopathy : Insights from Drosophila models and human brain samples

AlzDiabetes

Alzheimer's disease (AD) is the most common neurodegenerative disorder affecting about 20 million people worldwide. Although aging is considered to be the most important risk factor for Alzheimer's disease, growing evidence from epidemiological studies suggest that type-2 diabetes (T2DM) increases the risk factor of AD. While compelling evidence...

Funding Programme
Start Date
End Date
Total Funding
€ 183 455
European Countries Involved

Integrated Technology Ecosystem for ProACTive Patient Centred Care

ProACT

ProACT targets Europe’s 50 million multimorbid patients to proactively self-manage and offset the EU’s annual €700billion cost of chronic disease management. ProACT aims at providing and evaluating an open application programming interface to integrate a variety of new and existing technologies to advance ‘home based’ integrated care (IC). Cloud...

Funding Programme
Start Date
End Date
Total Funding
€ 4 876 709
European Countries Involved

Integration and analysis of heterogeneous big data for precision medicine and suggested treatments for different types of patients

IASIS

The vision of IASIS is to turn the wave of data heading our way into actionable knowledge for decision makers. This will be achieved by integrating data from disparate sources, including genomics, electronic health records and bibliography, and applying advanced analytics methods to discover useful patterns. Big Data in healthcare is in its early...

Funding Programme
Start Date
End Date
Total Funding
€ 4 337 475
European Countries Involved

Integration of AAL Components for Innovative Care Pathways

IntegrAAL

Internet-based and micro technologies have changed the way we live. But elderly people receiving care have not always benefited from these developments. IntegrAAL uses technology to help improve care for older people. Older people are often cared for by many different people, known as a circle of care. This circle may include informal carers as...

Funding Programme
Start Date
End Date
Total Funding
€ 1 200 000
European Countries Involved

Interdisciplinary Network for Dementia Utilising Current Technology (INDUCT)

INDUCT

Dementia raises complex challenges for people with dementia, their families, and society. The European Parliament has called for investment in high quality, innovative technology research to improve dementia care but so far there has been little benefit because research has generally been limited, small scale and methodologically flawed. In...

Funding Programme
Start Date
End Date
Total Funding
€ 3 878 757
European Countries Involved

Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain

IM2PACT

The overall aim is to further the understanding of the BBB in health and disease states towards the development of innovative brain delivery systems, especially for biopharmaceuticals (e.g., peptides, antibodies, etc.) and the identification of novel disease drug targets (Alzheimer’s Disease, MS, metabolic disease).

The related key deliverables...

Funding Programme
Start Date
End Date
Total Funding
€ 17 410 136

Investigating the impact of meditation training on mental health and wellbeing in the ageing population

MEDIT-AGEING

As the number of older people in Europe grows, increasing healthy life years is a priority. Cognitive decline, dementia (e.g. Alzheimer’s disease, AD), sleep disturbances and depression, all related to psychological distress and anxiety, are significant drivers of reduced quality of life in older adults. This project builds on evidence that...

Funding Programme
Start Date
End Date
Total Funding
€ 7 087 230
European Countries Involved

Investigation of the relationship between the material properties of insoluble, protein aggregates known as amyloids and common forms of age-related dementia such as Alzheimer’s and Parkinson’s

NANOMECHAMYLOID

The conversion of normally soluble and functional proteins into insoluble protein aggregates known as amyloids are linked to more than 50 human disorders, including several common forms of age-related dementia such as Alzheimer’s and Parkinson’s diseases. Amyloids exist as long, rope-like structures known as fibrils which can self-associate into...

Funding Programme
Start Date
End Date
Total Funding
€ 282 561
European Countries Involved

Joint Action on Dementia 2015-2018

Joint Action on Dementia 2015-2018. The Joint Action will focus on two phases on work: approximately 12 months on developing a consensus on the best evidence of effective action in 4 key areas (diagnosis and post-diagnostic support; crisis and care coordination; quality of care in residential care settings; and dementia-friendly communities); and...

Funding Programme
Start Date
End Date
Total Funding
€ 1 498 710
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).